Search

Multiple copies of a gene called YES1 appear to be responsible for certain precision drugs losing their effectiveness.

… Thursday, June 7, 2018 Summary A collaborative study between scientists at Memorial Sloan Kettering and the New York Genome Center has identified one way that lung cancer cells outsmart a common targeted drug therapy. The results, reported in the Proceedings of the National Academy of Sciences, pave

Radiologist and molecular imaging researcher Moritz Kircher was awarded a Brain and Immuno-Imaging Grant by The Dana Foundation. This three-year grant supports the development of a dual-modality MRI-Raman nanoparticle that allows combined pre-and intra-operative visualization of glioblastomas.

… Wednesday, November 30, 2011 Radiologist and molecular imaging researcher Moritz Kircher  was awarded a Brain and Immuno-Imaging Grant by The Dana Foundation. This three-year grant supports the development of a dual-modality MRI-Raman nanoparticle that allows combined pre-and intra-operative visualization

A surprising finding challenges long-held dogma about how certain immune cells develop into specialized types in diverse tissues.

… Thursday, September 8, 2016 Summary Macrophages are immune cells that exist in diverse forms in various tissues. They interact constantly with cancer cells and appear to both target them and assist them under different circumstances. A new finding sheds light on how macrophages develop into different

Learn about MSK's expertise and compassion in caring for people under 50 who are facing cancer.

… Friday, June 6, 2025 When 26-year-old Jo Luzarraga was diagnosed with breast cancer in Manila, Philippines, her older sister Jan Claire swung into action. “I told her, you’re moving to Queens, New York, to live with me and my daughter and my partner,” says Jan Claire, who is 40. “And you’re going to

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

… Tuesday, April 30, 2013 Summary Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide. Targeted therapies hold promise for the treatment of many types of cancer. But a common predicament is that in many patients

Learn why post-doctoral researcher Mijin Kim believes Memorial Sloan Kettering is an excellent choice for early career biomedical researchers, as she enjoys her recognition as a STAT Wunderkind, class of 2023.

… Tuesday, October 17, 2023 Mijin Kim, PhD, a postdoctoral researcher at Memorial Sloan Kettering Cancer Center (MSK), has been recognized with the prestigious  Wunderkind award by STAT , the well-regarded news site covering science and medicine. Each year, STAT seeks to find “the best researchers in health

Memorial Sloan Kettering Cancer Center (MSK) researchers presented breakthrough findings for new treatment approaches in several cancer indications at the European Society for Medical Oncology (ESMO) Congress 2022, held September 9 to 13 in Paris. Highlights included clinically meaningful benefits for new treatment strategies in advanced bladder cancer, endometrial cancer, and renal cell carcinoma. Additionally, MSK experts shared their perspectives on previously reported groundbreaking trials of new treatment approaches in colorectal cancer and HER2-low metastatic breast cancer.

… Tuesday, October 11, 2022 Advanced Bladder Cancer: Promising Results for Enfortumab Vedotin Plus Pembrolizumab MSK has been spearheading the development and testing of antibody-drug conjugates — novel biopharmaceuticals that deliver precise payloads of anti-cancer agents directly to cancer cells — alone

During a virtual awards ceremony, MSK and the Robbins Family Foundation recognized eight distinguished MSK staff members and one team for their exemplary service. Each member was honored with the 2021 Robbins Family Award for Nursing Excellence.

… Wednesday, May 12, 2021 Elizabeth McCormick, Senior Vice President, and Chief Nursing Executive Elizabeth McCormick, Senior Vice President, and Chief Nursing Executive MSK Nurses celebrate Nurses Week, May 6-12 MSK Nurses celebrate Nurses Week, May 6-12 MSK Nurses celebrate Nurses Week, May 6-12 MSK

Memorial Sloan Kettering Cancer Center (MSK) today announced that it has been awarded a Specialized Programs of Research Excellence (SPORE) grant for pancreatic research by the National Cancer Institute (NCI).

… Tuesday, October 11, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced that it has been awarded a Specialized Programs of Research Excellence (SPORE) grant for pancreatic research by the  National Cancer Institute (NCI) . The long-term goal of the grant is to demonstrate that prospective

Memorial Sloan Kettering’s 37th annual academic Convocation and the fifth Louis V. Gerstner Graduate School of Biomedical Sciences Commencement shared the spotlight on May 19.

… Tuesday, July 5, 2016 An afternoon ceremony on May 19 celebrated MSK’s 37th annual Convocation and the fifth Louis V. Gerstner Graduate School of Biomedical Sciences Commencement. Presided over by MSK President and CEO Craig Thompson , it recognized students who conducted their doctoral dissertation